IM Cannabis (IMCC) Accounts Payables (2019 - 2026)

IM Cannabis' Accounts Payables history runs 8 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• On a quarterly basis, Accounts Payables fell 46.47% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 46.47% decrease from a year earlier, with the FY2025 full-year figure at $8.6 million, up 6.06% from the prior year.
• Accounts Payables slipped to $6.0 million in Q1 2026 per IMCC's latest filing, from $8.6 million in the prior quarter.
• Across five years, Accounts Payables topped out at $12.1 million in Q3 2024 and bottomed at $5.2 million in Q3 2025.
• The 5-year median for Accounts Payables is $8.6 million (2025), against an average of $8.8 million.
• Across the five-year window, Accounts Payables jumped 204.67% in 2022 and slumped 57.24% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $11.3 million in 2022, then sank by 39.94% to $6.8 million in 2023, then gained by 17.91% to $8.0 million in 2024, then grew by 8.22% to $8.6 million in 2025, then plunged by 30.8% to $6.0 million in 2026.
• Per Business Quant, the three latest IMCC Accounts Payables figures stand at $6.0 million (Q1 2026), $8.6 million (Q4 2025), and $5.2 million (Q3 2025).